Buchumschlag

Precision therapy for cancer prevention by targeting carcinogenesis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Guoguo Jin, Kangdong Liu, Zhiping Guo, Zigang Dong
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Molecular Carcinogenesis
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Plakophilin 1 in carcinogenesis
von: Qiang Luo, et al.
Veröffentlicht: (2024)

Cover Image, Volume 63, Issue 5
von: Mengqiu Song, et al.
Veröffentlicht: (2024)

Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
von: Mengqiu Song, et al.
Veröffentlicht: (2024)

SRPK1 Activation Facilitates Gli3S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma
von: Yongwei Ding, et al.
Veröffentlicht: (2025)

Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk
von: Xiaohui Sun, et al.
Veröffentlicht: (2024)

Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy
von: Xing Ma, et al.
Veröffentlicht: (2024)

Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis
von: Ram Raj Prasad, et al.
Veröffentlicht: (2024)

Prenatal arsenic exposure alters keratinocyte stem cell fate through persistent activation of IGF2R‐MAPK cascade leading to aggravated skin carcinogenesis in mice offspring
von: Anchal Chauhan, et al.
Veröffentlicht: (2024)

The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
von: Anna Han, et al.
Veröffentlicht: (2024)

Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity
von: Kieun Bae, et al.
Veröffentlicht: (2024)

Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer
von: Qi Zhang, et al.
Veröffentlicht: (2024)

Tissue‐of‐origin for cancers determines HIF‐1 activation induced phenotypic heterogeneity
von: Shaofei Liu, et al.
Veröffentlicht: (2024)

γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway
von: Hao Zhu, et al.
Veröffentlicht: (2024)

C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer
von: Bo Liu, et al.
Veröffentlicht: (2024)

ABHD6 suppresses colorectal cancer progression via AKT signaling pathway
von: Xiaoyu Xiong, et al.
Veröffentlicht: (2024)

The mechanism of RGS5 regulating gastric cancer mismatch repair protein
von: Zhenwei Yang, et al.
Veröffentlicht: (2024)

PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer
von: Yunyun Liu, et al.
Veröffentlicht: (2024)

Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
von: Keping Deng, et al.
Veröffentlicht: (2024)

Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway
von: Junfeng Li, et al.
Veröffentlicht: (2024)

Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma
von: Hongyan Lu, et al.
Veröffentlicht: (2024)

MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer
von: Pengpeng Liu, et al.
Veröffentlicht: (2024)

Baicalein promotes KDM4E to induce BICD1 and inhibit triple‐negative breast cancer progression by blocking PAR1 signaling
von: Yun Dong, et al.
Veröffentlicht: (2024)

ITGA7 loss drives the differentiation of adipose‐derived mesenchymal stem cells to cancer‐associated fibroblasts
von: Xiaoli Liu, et al.
Veröffentlicht: (2024)

Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression
von: Yunho Jin, et al.
Veröffentlicht: (2024)

KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2
von: Lei Zhong, et al.
Veröffentlicht: (2024)

ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway
von: Hongqin Ma, et al.
Veröffentlicht: (2024)

Potentially functional genetic variants in interferon regulatory factor family genes are associated with colorectal cancer survival
von: Xiaoxia Tong, et al.
Veröffentlicht: (2024)

Oscillatory hypoxia induced gene expression predicts low survival in human breast cancer patients
von: Yasir Suhail, et al.
Veröffentlicht: (2024)

Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling
von: Jing Peng, et al.
Veröffentlicht: (2024)

Deciphering CD4+ T cell‐mediated responses against cancer
von: Catherine Kirkpatrick, et al.
Veröffentlicht: (2024)

Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition
von: Fangquan Chen, et al.
Veröffentlicht: (2024)

microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2
von: Qing Xia, et al.
Veröffentlicht: (2024)

JD‐02, a novel Hsp90 inhibitor, induces ROS/SRC axis‐dependent cytoprotective autophagy in colorectal cancer cells
von: Ni Lan, et al.
Veröffentlicht: (2024)

Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression
von: Waseem Raza, et al.
Veröffentlicht: (2024)

β‐Elemene Inhibits Adrenocortical Carcinoma Cell Proliferation and Migration, and Induces Apoptosis by Up‐Regulating miR‐486‐3p/Targeting NPTX1 Axis
von: Yan Lin, et al.
Veröffentlicht: (2025)

Alternative splicing‐related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR‐199a‐5p/SRSF1 axis and impacting Anillin
von: Yifan Zhang, et al.
Veröffentlicht: (2024)

KIF4A Inhibits Ferroptosis in Glioblastoma via the CHMP4B/GPX4 Axis and Promotes Temozolomide Resistance
von: Xinan Shen, et al.
Veröffentlicht: (2025)

Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
von: Takashi Furusawa, et al.
Veröffentlicht: (2024)

Venetoclax Synergizes With Regorafenib for Colorectal Cancer by Targeting BCL‐2
von: Lijun Zhu, et al.
Veröffentlicht: (2025)

HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer
von: Xue Yang, et al.
Veröffentlicht: (2024)